Secukinumab gets one step closer to approval in Europe for treating psoriasis.

[jiml]

But now it is interesting and bad news for our friends with MS.
Previously there was a medication Lemtrada, or alemtuzumab, which was working against leukemia.
It was removed from the market in 2012.
Now recently it has been set back into the market, because it also appears to slow down the progress of MS, exactly the same product, for a price ................... 40 times more expensive.

Are we being ripped off by the big pharma companies ........ Yes most definitely .....shame on them .... Reinstating a product at vastly inflated prices......., and why...... Because they can